- Back to menuPrices
- Back to menuResearch
- Back to menu
- Back to menu
- Back to menu
- Back to menu
- Back to menuWebinars & Events
Features
ICO First: Farm Collective Wins Clearinghouse Approval for Token Sale
The first initial coin offering in Russia sanctioned by a traditional clearing house is underway, a step toward legitimization of blockchain tokens.
It's Political: Why China Hates Bitcoin and Loves the Blockchain
CoinDesk advisor Michael Casey explains China’s recent moves against bitcoin exchanges and ICOs in a wider geopolitical context.
Back Above $4,000: Bitcoin Eyes Next Major Price Hurdle
The bitcoin price is inching higher on the day. But with $4,000 breached, $4,123 may be the next number traders want to watch.
First Cash, Now Gold? Another Bitcoin Hard Fork Is on the Way
A plan to hard fork the bitcoin blockchain, and change its mining algorithm, is emerging. Still in its early stages, what does the new coin offer?
Through the Roadblock? Bitcoin's Price Might Be Priming for a Boost
Bearish signals appear to be reversing as chart analysis suggests the quiet bitcoin price might be close to making noise.
Like It or Not: Public Companies Are Feeling the Crypto Mining Boom
Public companies like AMD and Nvidia are benefiting from a surge in cryptocurrency mining, but analysts say they may not be ready to commit long-term.
MimbleWimble Won't ICO But Will Launch Cryptocurrency
One of the more theoretical attempts at scaling blockchain networks is taking steps toward launching it's own network for further testing.
Neo ICO Token Wins Traders as China Worries Fade
A popular ICO token launched in China is showing signs of recovery, weeks after the country took moves to limit similar domestic activities.
Wait and Watch? Bitcoin Prices Hover Near Make or Break Level
The price of bitcoin may be headed toward a fork in the road, if current chart analysis is any indication.
Payment or Asset? Bitcoin's Limbo Is Leaving Merchants in the Middle
Is bitcoin more of a payment mechanism or an investment asset? A recent trial by a supermarket chain could shed light on the debate.
